Beijing Wandong Medical Technology Co.,Ltd. (SHA:600055)
China
· Delayed Price · Currency is CNY 14.98
-0.03 (-0.20%)
Mar 10, 2026, 11:15 AM CST
SHA:600055 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,553 | 10,616 | 12,008 | 13,738 | 12,759 | 5,423 | Upgrade
|
| Market Cap Growth | -8.53% | -11.59% | -12.59% | 7.67% | 135.28% | -2.83% | Upgrade
|
| Enterprise Value | 7,565 | 7,371 | 8,825 | 10,643 | 11,775 | 4,670 | Upgrade
|
| Last Close Price | 15.01 | 14.99 | 16.80 | 19.11 | 23.20 | 9.79 | Upgrade
|
| PE Ratio | 732.45 | 67.47 | 63.69 | 78.34 | 69.65 | 24.58 | Upgrade
|
| Forward PE | - | 48.42 | 48.42 | 47.66 | 62.66 | 22.74 | Upgrade
|
| PS Ratio | 6.52 | 6.96 | 9.71 | 12.25 | 11.04 | 4.79 | Upgrade
|
| PB Ratio | 2.20 | 2.18 | 2.49 | 2.92 | 5.10 | 2.28 | Upgrade
|
| P/TBV Ratio | 2.26 | 2.24 | 2.56 | 3.00 | 5.38 | 2.40 | Upgrade
|
| P/FCF Ratio | - | 59.10 | 62.84 | 80.17 | 163.85 | 10.91 | Upgrade
|
| P/OCF Ratio | - | 48.64 | 57.67 | 74.10 | 142.21 | 10.43 | Upgrade
|
| EV/Sales Ratio | 4.67 | 4.84 | 7.14 | 9.49 | 10.18 | 4.13 | Upgrade
|
| EV/EBITDA Ratio | - | 61.78 | 78.71 | 68.13 | 53.23 | 14.97 | Upgrade
|
| EV/EBIT Ratio | - | 86.37 | 111.63 | 85.20 | 63.07 | 17.08 | Upgrade
|
| EV/FCF Ratio | -28.81 | 41.03 | 46.18 | 62.11 | 151.20 | 9.40 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | - | 0.21 | 0.15 | 0.14 | 0.08 | 0.03 | Upgrade
|
| Debt / FCF Ratio | - | 0.15 | 0.09 | 0.13 | 0.24 | 0.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.65 | -0.73 | -0.71 | -0.70 | -0.44 | -0.49 | Upgrade
|
| Net Debt / EBITDA Ratio | 115.67 | -29.84 | -30.53 | -21.25 | -5.03 | -3.71 | Upgrade
|
| Net Debt / FCF Ratio | 11.80 | -19.82 | -17.91 | -19.37 | -14.30 | -2.33 | Upgrade
|
| Asset Turnover | 0.29 | 0.28 | 0.23 | 0.28 | 0.40 | 0.42 | Upgrade
|
| Inventory Turnover | 2.70 | 3.29 | 2.23 | 2.75 | 2.89 | 2.65 | Upgrade
|
| Quick Ratio | 4.70 | 7.87 | 7.59 | 7.98 | 4.94 | 3.55 | Upgrade
|
| Current Ratio | 5.42 | 8.32 | 8.38 | 8.67 | 5.67 | 4.17 | Upgrade
|
| Return on Equity (ROE) | 0.30% | 3.27% | 4.00% | 4.77% | 7.38% | 9.57% | Upgrade
|
| Return on Assets (ROA) | -0.70% | 0.98% | 0.93% | 1.92% | 4.07% | 6.30% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.59% | 5.98% | 5.07% | 8.03% | 12.43% | 16.91% | Upgrade
|
| Return on Capital Employed (ROCE) | -1.30% | 1.70% | 1.60% | 2.60% | 7.30% | 11.30% | Upgrade
|
| Earnings Yield | 0.14% | 1.48% | 1.57% | 1.28% | 1.44% | 4.07% | Upgrade
|
| FCF Yield | -2.49% | 1.69% | 1.59% | 1.25% | 0.61% | 9.16% | Upgrade
|
| Dividend Yield | 0.87% | 0.87% | 0.77% | 0.63% | 0.43% | 1.33% | Upgrade
|
| Payout Ratio | 635.14% | 58.09% | 44.75% | 40.09% | 38.03% | 12.74% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | -0.22% | -6.31% | -23.08% | -0.01% | 0.73% | Upgrade
|
| Total Shareholder Return | 0.89% | 0.64% | -5.54% | -22.45% | 0.42% | 2.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.